Biomaterial Database

Does hyperprolactinaemia predispose to aluminium toxicity in chronic renal failure? 1994

P J Garrett

UI	MeSH Term	Description	Entries
D006966	Hyperprolactinemia	Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)	Prolactin Hypersecretion Syndrome,Prolactin, Inappropriate Secretion,Hyperprolactinaemia,Inappropriate Prolactin Secretion,Inappropriate Prolactin Secretion Syndrome,Hyperprolactinemias,Hypersecretion Syndrome, Prolactin,Inappropriate Secretion Prolactin,Prolactin Secretion, Inappropriate,Secretion Prolactin, Inappropriate,Secretion, Inappropriate Prolactin,Syndrome, Prolactin Hypersecretion
D007676	Kidney Failure, Chronic	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000535	Aluminum	A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.	Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27

Related Publications

P J Garrett

Does hyperprolactinaemia predispose to aluminium toxicity in chronic renal failure?

January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

P J Garrett

Aluminium retention and toxicity in chronic renal failure.

April 1972, Lancet (London, England),

P J Garrett

Aluminium toxicity in chronic renal insufficiency.

August 1985, Clinics in endocrinology and metabolism,

P J Garrett

Aluminium and chronic renal failure.

November 1971, British medical journal,

P J Garrett

Ranitidine reduces aluminium toxicity in patients with renal failure.

January 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

P J Garrett

Aluminium and bone disease in chronic renal failure.

January 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

P J Garrett

Aluminium intoxication in undialysed adults with chronic renal failure.

August 1992, Journal of neurology, neurosurgery, and psychiatry,

P J Garrett

Hypochromic anaemia in chronic renal failure--role of aluminium.

July 1999, The Journal of the Association of Physicians of India,

P J Garrett

Hypochronic anemia in chronic renal failure--role of aluminium.

May 2000, The Journal of the Association of Physicians of India,

P J Garrett

Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).

January 1985, Clinical nephrology,